Medical/Pharmaceuticals

Angel Yeast Launches Patented Saccharomyces Boulardii Bld-3, a Strain of Yeast Probiotic Effective Against Diarrhea

YICHANG, China, Sept. 2, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast" or "Angel"), a listed high-tech yeast company inChina, announced its nutritional R&D team has developed a new strain of yeast probiotic,Saccharomyces boulardii Bld-3 (S. boulardii Bld-3) ...

2021-09-02 22:43 6114

Insilico Medicine Appoints the Former Chief Medical Officer of Schering Plough, Dr. Robert Spiegel, MD, FACP, as acting Chief Medical Officer (CMO) to Oversee the Clinical Translation of its Preclinical Pipeline Assets

SHANGHAI and NEW YORK, Sept. 2, 2021 /PRNewswire/ -- Insilico Medicine, an end-to-end AI-powered drug discovery company, today announced the appointment of Robert Spiegel as acting CMO to oversee the clinical translation of its preclinical pipeline assets. Dr. Spiegel brings over 35 years of exte...

2021-09-02 21:00 4297

Rapid acceleration of medical education for Japan's medical students using VR - NHK special feature published online

TOKYO, Sept. 2, 2021 /PRNewswire/ -- At many Japanese institutions offering medical education, medical students are unable to attend clinical practice due to the spread of COVID-19, denying them the experience of valuable opportunities to learn. Efforts by Jolly Good and Nippon Medical School to...

2021-09-02 21:00 2681

I-Mab Added to FTSE Russell Global Equity Index Series

SHANGHAI and GAITHERSBURG, Md., Sept. 2, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that I-Mab will be added to the following FTSE Global Eq...

2021-09-02 20:00 6620

High-end Global Computed Tomography Purchases to Propel the High-end CT Segment Revenue

CT market is expected to reach $6.14 billion by 2025, registering steady growth at a CAGR of 8.1%, finds Frost & Sullivan SANTA CLARA, Calif., Sept. 2, 2021 /PRNewswire/ -- An estimated 375 million computed tomography (CT) procedures are carried out globally each year, increasing annually by 3%–...

2021-09-02 16:02 2026

Elekta acquires Turkish distributor to strengthen market position

STOCKHOLM, Sept. 2, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has acquired its long-time partner and Turkish distributor of neurosurgery solutions, Özyürek Mümessillik ve Dış Ticaret A.Ş. (Özyürek A.Ş.). The acquisition will improve Elekta's market access in the region and ...

2021-09-02 14:16 4904

CStone announces China's NMPA has accepted its new drug application for sugemalimab in the treatment of stage III NSCLC

* Sugemalimab becomes the world's first anti-PD-1/PD-L1 monoclonal antibody to significantly improve progression-free survival (PFS) in patients with stage III non-small cell lung cancer (NSCLC) without disease progression after concurrent or sequential chemoradiotherapy * The new drug applic...

2021-09-02 08:05 4601

Innovent and GenFleet Announce Exclusive Global License Agreement for GFH925 (KRAS G12C Inhibitor)

SAN FRANCISCO and SUZHOU, China, Sept. 2, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...

2021-09-02 08:00 6236

REPROCELL signs Strategic Collaboration Agreement with TEXCELL to boost its GMP iPSC - Master Cell Bank Manufacturing Service

YOKOHAMA, Japan, Sept. 2, 2021 /PRNewswire/ -- REPROCELL have signed a Strategic Collaboration Agreement with TEXCELLJAPAN, a TEXCELL Group Company, for GMP iPSC - Master Cell Banks (MCB) Manufacturing. The TEXCELL Group (hereinafter "TEXCELL") is a contract manufacturing organization (CMO) head...

2021-09-02 03:43 1893

Insilico Medicine Collaborates with Gray Matter to Fight Age-related Cognitive Decline

HONG KONG, Sept. 1, 2021 /PRNewswire/ -- Insilico Medicine is pleased to announce an R&D collaboration with Gray Matter, a longevity biotechnology company focused on peptide-based interventions against cognitive decline, age-related CNS diseases, and aging. This strategic partnership is intended ...

2021-09-01 22:08 3869

EmitBio Results Yield 99.99% Reduction of Delta in Human Tissue

New data proves technology neutralizes the Delta variant Third Human Trial Underway DURHAM, N.C., Sept. 1, 2021 /PRNewswire/ -- EmitBio, Inc., a life science company, today announced successful results from a new In Vitro Neutralization study of the Delta variant in human airway tissue. The stud...

2021-09-01 21:00 1791

EmitBio Results Yield 99.99% Reduction of Delta in Human Tissue

New data proves technology neutralizes the Delta variant Third Human Trial Underway DURHAM, N.C., Sept. 1, 2021 /PRNewswire/ -- EmitBio, Inc., a life science company, today announced successful results from a new In Vitro Neutralization study of the Delta variant in human airway tissue. The stud...

2021-09-01 21:00 2614

Seegene Receives CE-IVD Mark for Use of Combo Swab, a Self-Collection Device with Four COVID-19 Diagnostic Tests

SEOUL, South Korea, Sept. 1, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, announced on August 20 that it has obtained CE marking for the use of Combo Swab, a self-collection device with four diagnostic assays. Combo Swab is a user-friendly...

2021-09-01 17:40 2285

Hummingbird Bioscience Strengthens Leadership Team with Appointment of Josh House as Chief Financial Officer

HOUSTON and SINGAPORE, Sept. 1, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced the appointment of Josh House as Chief Financial Officer, effective immediately. Dr....

2021-09-01 17:00 1756

Harbour BioMed Announces IND Approval for Phase II Trial of Anti-FcRn Batoclimab in Chronic Inflammatory Demyelinating Polyneuropathy in China

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Sept. 1, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) today announced that the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) appl...

2021-09-01 13:05 3305

SK magic provides clean air and water to Malaysians at COVID-19 vaccine centers and hospitals

KUALA LUMPUR, Malaysia, Sept. 1, 2021 /PRNewswire/ -- In support of the National COVID-19 Immunisation Programme, SK magic, the leading home appliance company fromSouth Korea, equipped Covid-19 Vaccination Centres (CVCs) and treatment hospitals with its air and water purifiers to provide fresh and...

2021-09-01 11:49 3429

Zymo Research Receives CE Mark for New SafeCollect™ At-Home Sample Collection Kits

Self-collection devices designed for ease of use and safety IRVINE, Calif., Sept. 1, 2021 /PRNewswire/ -- Zymo Research announced today its new line of at-home sample collection kits has received CE marking for sale in the European Union (EU). TheSafeCollect™ Sample Collection Kits were designed...

2021-09-01 11:05 3897

SynForU(TM)-HerCare probiotics shows benefits to reduce vaginal yeast infection in pregnant women

KAOHSIUNG, Taiwan, Sept. 1, 2021 /PRNewswire/ -- The first clinical study which has been published in the Journal of Applied Microbiology documents that SynForU™-HerCare is effective in reducing vulvovaginal symptoms and recurrences of vaginal candidiasis (VC) in pregnant women.

2021-09-01 09:00 5212

MedAlliance Announces First Patient Enrolled in the 3,300 Patient Landmark Sirolimus DEB vs DES Study

GENEVA, Sept. 1, 2021 /PRNewswire/ -- MedAlliance is pleased to announce the enrollment of the first patient in the ground-breaking coronary randomized controlled study "SELUTION DeNovo". This study utilizes SELUTION SLR™, a novel sirolimus drug-eluting balloon [DEB], versus a limus drug-eluting ...

2021-09-01 08:00 2969

European Stroke Organisation Conference (ESOC) 2021: Non-traditional risk factors for heart attack and stroke rising more steeply in women, major study reveals

BASEL, Switzerland, Sept. 1, 2021 /PRNewswire/ -- Work stress, sleep disorders, and fatigue, regarded as non-traditional risk factors for heart attack and stroke, are rising more steeply amongst women than men, according to a new study presented today at the European Stroke Organisation (ESO) Con...

2021-09-01 06:00 3069
1 ... 608609610611612613614 ... 649